Back
Cytokinetics Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
44
CYTK
Cytokinetics
Last Price:
53.80
Seasonality Move:
-7.7%
Sell
41
SRPT
Sarepta Therapeutics
Last Price:
127.17
Seasonality Move:
0.19%
Sell
44
Cytokinetics (CYTK)
is a Sell
Is Cytokinetics a Buy, Sell or Hold?
- The current Cytokinetics [CYTK] share price is $53.78. The Score for CYTK is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- CYTK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $127.17. The Score for SRPT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CYTK Stock Price Chart
What is Cytokinetics's stock price today?
-
The Cytokinetics share price today is $53.78
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTK is experiencing selling pressure, which indicates risk of future bearish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $127.17
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight buying pressure.
CYTK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.25 | Sell |
| Relative Strength Index (14 RSI): | 42.85 | Sell |
| Chaikin Money Flow: | -1785179 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (54.65 - 56.89) | Sell |
| Bollinger Bands (100): | (52.2 - 59.78) | Sell |
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.52 | Sell |
| Relative Strength Index (14 RSI): | 38.9 | Sell |
| Chaikin Money Flow: | 50230 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (126.71 - 139.27) | Sell |
| Bollinger Bands (100): | (124.42 - 147.62) | Sell |
CYTK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 55.24 | Sell |
| 20-day SMA: | 55.58 | Sell |
| 50-day SMA: | 56.19 | Sell |
| 200-day SMA: | 62.91 | Sell |
| 8-day EMA: | 55.23 | Sell |
| 20-day EMA: | 55.48 | Sell |
| 50-day EMA: | 55.93 | Sell |
| 200-day EMA: | 56.43 | Sell |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 125.97 | Buy |
| 20-day SMA: | 131.43 | Sell |
| 50-day SMA: | 137.6 | Sell |
| 200-day SMA: | 126.61 | Buy |
| 8-day EMA: | 126.89 | Buy |
| 20-day EMA: | 130.12 | Sell |
| 50-day EMA: | 134.31 | Sell |
| 200-day EMA: | 128.83 | Sell |
Cytokinetics Earnings Growth & CYTK Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.49 per share, a decrease next quarter of $0.09 per share, a decrease this year of $0.28 per share, and an increase next year of $0.22 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.96 per share, an increase next quarter of $2.81 per share, an increase this year of $4.41 per share, and an increase next year of $9.14 per share.
Cytokinetics Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sarepta Therapeutics Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||